NCT07070986

Brief Summary

Anxiety is a natural response to stress which peaks just before the surgery procedure. High levels of anxiety can increase postoperative pain and complications. Medicated anxiolysis is no longer recommended, in the absence of proven efficacy. Other interventions to prevent anxiety are required. The autonomic nervous system (ANS), both sympathetic and parasympathetic, determines the response to stress. Anxiety interventions such as hypnosis, massage and relaxation work by modulating ANS tone. The ANS also modulates heart rate. Anxiety can be measured by RR space, from which HRV, high-frequency (HF) and low-frequency (LF) are components respectively linked to the parasympathetic and sympathetic systems. The LF/HF ratio reflects sympathetic dominance if high, and parasympathetic dominance if low. Cutaneous resonance stimulation (RESC) is a manual technique. RESC can diagnose and correct energy imbalances by skin stimulation between two points and thus act on anxiety. We hypothesized that a preoperative RESC session would modify the sympathetic/parasympathetic balance and reduce anxiety in patients admitted for cardiac surgery, compared to patient receiving a sham RESC session: non-specific cutaneous stimulation (NSCS).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2025Mar 2027

First Submitted

Initial submission to the registry

June 23, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 30, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2027

Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

June 23, 2025

Last Update Submit

December 13, 2025

Conditions

Keywords

AnxietyCardiac surgeryPainRESC

Outcome Measures

Primary Outcomes (1)

  • LF/HF ratio variation compared between the groups

    LF and HF will be monitored during the all RESC/NSCS.

    Between the beginning and the end of the RESC/NCS session (20 minutes)

Secondary Outcomes (9)

  • Skin conductance variation compared between the groups

    Between the beginning and the end of the RESC/NCS session (20 minutes)

  • Perfusion index variations compared between the groups.

    Between the beginning and the end of the RESC/NCS session (20 minutes)

  • Analgesia nociception index compared between the groups

    Between the beginning and the end of the RESC/NCS session (20 minutes)

  • Anxiety compared between the groups

    After de RESC/NCS session

  • Morphine use post-surgery compared between the groups

    Day 1

  • +4 more secondary outcomes

Study Arms (2)

CUTANEOUS RESONANCE STIMULATION (RESC)

If randomized in the RESC group, interventional group, patient will receive a 20 minutes session of cutaneous resonance stimulation before his cardiac surgery according to a standardized protocol.

Procedure: RESC

NON SPECIFIC CUTANEOUS STIMULATION (NSCS)

If randomized in the NSCS group, control group, patient will receive a 20 minutes session of non-specific cutaneous stimulation before his cardiac surgery according to a standardized protocol.

Other: NSCS

Interventions

RESCPROCEDURE

If randomized in the RESC group, interventional group, patient will receive a 20 minutes session of cutaneous resonance stimulation before his cardiac surgery. He will be asked to respond to anxiety questionnaire STAI-E and to evaluate his anxiety on a visual analogue scale (VAS) at J-1 (day of inclusion), J0 (day of surgery), and J1 (the day after surgery). During the RESC session, LF/HF ratio, ANI, heart rate, respiratory rate, perfusion index and skin conductance will be monitored.

CUTANEOUS RESONANCE STIMULATION (RESC)
NSCSOTHER

If randomized in the NSCS group, interventional group, patient will receive a 20 minutes session of non-specific cutaneous stimulation before his cardiac surgery. He will be asked to respond to anxiety questionnaire STAI-E and to evaluate his anxiety on a visual analogue scale at J-1 (day of inclusion), J0 (day of surgery), and J1 (the day after surgery) During the NSCS session, LF/HF ratio, ANI, heart rate, respiratory rate, perfusion index and skin conductance will be monitored.

NON SPECIFIC CUTANEOUS STIMULATION (NSCS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted for cardiac surgery with significant preoperative anxiety.

You may qualify if:

  • Planned cardiac surgery with extracorporeal circulation
  • Pre operatory anxiety : STAI-E score \>30 or Visual Analogue Scale Anxiety \>6

You may not qualify if:

  • Urgent surgery
  • Atrial fibrillation
  • Impossibility to answer to STAI-E or VAS
  • Use of alternative method
  • Absence of consent
  • Pregnant, breastfeeding women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopitallouis Pradel

Bron, 69500, France

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2025

First Posted

July 17, 2025

Study Start

September 30, 2025

Primary Completion (Estimated)

March 3, 2027

Study Completion (Estimated)

March 3, 2027

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations